跳至主要内容
临床试验/NCT04706000
NCT04706000已完成不适用

Investigation of Autophagy Markers in Endometrial Polyps

Muğla Sıtkı Koçman University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年1月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
autophagy marker

研究概览

简要总结

The aim of this research is to evaluate autophagy markers in patients with endometrial polyps

详细描述

Endometrial polyp are benign formations that are frequently encountered in gynecology practice and have malignant potential. It may be asymptomatic in the clinic or may present with abnormal uterine bleeding. Although its pathophysiology has not been clearly revealed, there are many studies in the literature about it. However, the autophagy pathway emerges as a subject that has never been evaluated. In this study, the investigators would like to prospectively evaluate Beclin 1, LC3A / B and p62 markers in the autophagy pathway in endometrial polyp tissue samples by immunohistochemistry and reveal their importance.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients over 35 years of age with a histopathologically confirmed diagnosis of endometrial polyp
  • patients over the age of 35 whose histopathologically reported normal endometrial biopsy results.

排除标准

  • Are under the age of 35,
  • those with cognitive dysfunction,
  • diagnosed with any type of cancer
  • who are under treatment for cancer,
  • diabetes mellitus,
  • hypertension,
  • endometriosis,
  • adenomyosis,
  • chronic endometritis,
  • have an acute or chronic illness,
  • patients who have smoked and used alcohol in the last 10 years

结局指标

主要结局

autophagy marker

时间窗: through study completion, an average of 1 year

p62 gene level

次要结局

未报告次要终点

研究者

发起方
Muğla Sıtkı Koçman University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Burak Sezgin

Principal investigator M.D. Burak Sezgin

Muğla Sıtkı Koçman University

研究点 (1)

Loading locations...

相似试验